• 名称: HMy2.CIR(人B淋巴母细胞瘤细胞)
  • 货号: CBP60725
  • 浏览次数: 136
  • 已销售数量:0件
  • 评论信息
  • 购买数量:  购买数量不能低于最少订购数量!

购买 询价 收藏 QQ交流 好友推荐

CBP60725
I. General information 
Synonyms: HMy2.CIR
Background: The HMy2.CIR cell line was derived from the HMy.2 B lymphoblastoid cell line, a fast growing mutant of the ARH-77 cell line (ATCC CRL-1621), by gamma irradiation and selection for loss of HLA class I antigen expression.
Morphology: lymphoblast
Growth Mode: suspension
Doubling Time:  N/A
DNA Profile: Amelogenin: X
CSF1PO: 6,10
D13S317: 11,13
D16S539: 9,13
D5S818: 10,13
D7S820: 7,12
THO1: 8
TPOX: 8
vWA: 1
Cobioer’s Cell Line Authentication Service
Culture Medium: RPMI-1640+10%FBS
We strongly suggest to purchase the complete medium from Cobioer.
Cryopreservation medium: 90%FBS+10%DMSO
Antigen Expression: The CRL-1621cell line is reported to be positive for Epstein-Barr nuclear antigen (EBNA +) and Epstein-Barr viral capsid antigen (EBVCA +). 
Genes Expressed:  The cells express no HLA A or B locus products, but do express small amounts of HLA Cw4.
Comments: The cells are useful as host for transfected class I major histocompatibility antigen genes.
Since the HMy2.CIR cell line was derived from the HMy.2 B lymphoblastoid cell line, a fast growing mutant of the ARH-77 cell line (ATCC CRL-1621), it is assumed to be EBNA positive.
For more information, please contact Cobioer (4008-750-250).

关键词: